Teleflex Incorporated announced a leadership transition with Stuart Randle appointed Interim President and CEO.
Dr. Stephen Klasko appointed Chairman of the Board.
The Company provided an update on its preliminary full year 2025 revenue results.
Leadership Transition
Stuart Randle appointed Interim President and CEO, Dr. Stephen Klasko named Chairman of the Board.
Revenue Update
Full year 2025 revenue expected to be $3.270 billion to $3.278 billion, lower than previous guidance due to softer demand in certain segments.
Board Engagement
Spencer Stuart engaged for CEO search process, focusing on core critical care and high-acuity hospital markets.
- Teleflex is entering a new phase as a more focused, higher-growth organization with the announced sale of certain businesses.
- Revenue for 2025 is expected to be lower than previous guidance due to various factors impacting demand and order volumes.
Teleflex is positioning itself for a transformational phase with the leadership transition and strategic business focus. The Company continues to prioritize growth and value creation for its stakeholders.